MRI to predict response to dienogest for endometriosis
Part of Women’s health & pregnancy clinical trials.
This study uses MRI scans to see if they can predict how well dienogest, a hormone treatment, will work for endometriosis. If you have endometriosis and haven't used dienogest before, this trial could help find the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 19 and 45 years old.
- You have been diagnosed with endometriosis by a gynecologist.
- You have not had any hormone treatment in the last 3 months.
- You have never taken dienogest for endometriosis.
- You are not pregnant and do not plan to become pregnant in the next 6 months.
- You do not have any metal implants or other reasons that would prevent an MRI scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether MRI can improve diagnosis and surgical planning for people with deep endometriosis before they have laparoscopic surgery. It may help you if you have deep endometriosis and are already scheduled for an MRI and surgery.
This study looks at small molecules in saliva called microRNAs to see if they can help predict how well endometriosis responds to hormone therapy. It may help doctors choose the best treatment for you.
This trial studies whether special scans (PET/MRI) can help predict how well endometrial cancer patients will do. You may be asked to get these scans before surgery, and your results may help classify your cancer risk.
This trial uses MRI to diagnose pelvic endometriosis in patients who have not yet received treatment. It aims to see how well MRI can find endometriosis, which might help avoid surgery for diagnosis.
This study uses a combined PET/MRI scan to better see endometriosis in people who are already scheduled for laparoscopic surgery. It may help find spots of endometriosis that are hard to see with other tests.
This trial compares an implant that releases the hormone gestrinone with a daily pill called dienogest to see which works better for treating endometriosis symptoms. It might be a good option if you have mild to moderate endometriosis and are looking for a non-surgical treatment.
Hear when a new Endometriosis, Ovarian trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.